Global DPT Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global DPT Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.

According to our (Global Info Research) latest study, the global DPT Vaccines market size was valued at US$ 5541 million in 2023 and is forecast to a readjusted size of USD 6992 million by 2030 with a CAGR of 3.4% during review period.

Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.

This report is a detailed and comprehensive analysis for global DPT Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Age. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global DPT Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2019-2030

Global DPT Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2019-2030

Global DPT Vaccines market size and forecasts, by Type and by Age, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2019-2030

Global DPT Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (US$/Dose), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for DPT Vaccines

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global DPT Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

DPT Vaccines market is split by Type and by Age. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Age in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
DTaP
Tdap
DTwP

Market segment by Age
12 Months Below
12 Months Above

Major players covered
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe DPT Vaccines product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of DPT Vaccines, with price, sales quantity, revenue, and global market share of DPT Vaccines from 2019 to 2024.

Chapter 3, the DPT Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the DPT Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Age, with sales market share and growth rate by Type, by Age, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and DPT Vaccines market forecast, by regions, by Type, and by Age, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of DPT Vaccines.

Chapter 14 and 15, to describe DPT Vaccines sales channel, distributors, customers, research findings and conclusion.